MGI Tech Co., Ltd. Class A 688114

MGI Australia, the local Australia and New Zealand team of MGI Tech Co., Ltd. (MGI), has entered a Memorandum of Understanding (MOU) with QIMR Berghofer's National Centre for Spatial Tissue and AI Research (NCSTAR).

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Next Generation Sequencing Services Market size & share revenue was valued at approximately USD 6.8 Billion in 2025 and is expected to reach USD 8.3 Billion in 2026 and is expected to reach around USD 56.1 Billion by 2035, at a CAGR of 23.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc.,

MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, celebrates its 10th anniversary, a decade marked by breakthroughs that have helped transform genomics into a scalable, data-driven and accessible engine of discovery.

MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in the life sciences, today announced the acquisition of STOmics and CycloneSEQ. It marks a significant milestone in MGI's "SEQALL+GLI+Omics" strategy, positioning the company as the world's only manufacturer of core life science tools spanning short-read sequencing, long-read nanopore sequencing, generative lab intelligence and spatial omics technologies.

Canadian Next-Generation Sequencing (NGS) Market Canadian Next-Generation Sequencing (NGS) Market Dublin, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The "Canada Next-Generation Sequencing (NGS) Market - A Canada and Regional Analysis: Focus on Application, Technology, Offering, End User, and Regional Analysis - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering. The Canada next-generation sequencing (NGS) market is projected to reach $2.77 billion in 2035 and was estima